icone plus
Contact Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
UVzjqTwuZnjqMRSq
Listen
